
EpiCombi.AI applies machine learning to streamline drug discovery. It builds a new computational workflow for identifying cancer therapies and other diseases. The company leverages ML, data science, and biotech methods to run early-stage discovery. Category: B2B biotech with ML-powered drug discovery; typical customers are pharma and biotech teams. Based in Oxford, UK, it is at seed stage and aims to scale research collaborations.

EpiCombi.AI applies machine learning to streamline drug discovery. It builds a new computational workflow for identifying cancer therapies and other diseases. The company leverages ML, data science, and biotech methods to run early-stage discovery. Category: B2B biotech with ML-powered drug discovery; typical customers are pharma and biotech teams. Based in Oxford, UK, it is at seed stage and aims to scale research collaborations.